Centrally-acting α2-agonist
Clonidine hydrochloride
Brand names: Catapres, Dixarit
Adult dose
Dose: Hypertension: 50–100 micrograms TDS (max 1.2mg/day). Menopausal flushing: 50 micrograms BD. Migraine prophylaxis: 25–75 micrograms BD
Route: PO/IV
Frequency: BD-TDS
Paediatric dose
Dose: 1 micrograms/kg
Route: PO
Frequency: TDS-QDS
Max: 100 micrograms/dose
ADHD/sedation/withdrawal — initiate by specialist; range 1–5 micrograms/kg/dose
Paediatric weight-based calculator
ADHD/sedation/withdrawal — initiate by specialist; range 1–5 micrograms/kg/dose
Clinical pearls
- Never stop abruptly — taper over ≥1 week to prevent rebound HT crisis
- ICU sedation, opioid/alcohol withdrawal, ADHD specialist use, restless legs
Contraindications
- Severe bradyarrhythmia
- Sick sinus syndrome
Side effects
- Sedation
- Dry mouth
- Bradycardia
- Hypotension
- Rebound hypertension on abrupt withdrawal
- Depression
Interactions
- β-blockers (additive bradycardia; rebound hypertension worse)
- TCAs (reduced effect)
- CNS depressants
Monitoring
- BP
- HR
Reference: BNFc; BNF; https://bnf.nice.org.uk/drugs/clonidine-hydrochloride/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Pathways
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines